about
Methionine and seleno-methionine type peptide and peptoid building blocks synthesized by five-component five-center reactions.In vitro anticancer activity of gold(III) complexes with some esters of (S,S)-ethylenediamine-N,N'-di-2-propanoic acid.Interesting coordination abilities of antiulcer drug famotidine and antimicrobial activity of drug and its cobalt(III) complex.Study of the cytotoxic activity of di and triphenyltin(IV) carboxylate complexes.A multicomponent macrocyclization strategy to natural product-like cyclic lipopeptides: synthesis and anticancer evaluation of surfactin and mycosubtilin analogues.Anticancer metallotherapeutics in preclinical development.Increased betulinic acid induced cytotoxicity and radiosensitivity in glioma cells under hypoxic conditions.Evaluation of functionalized mesoporous silica SBA-15 as a carrier system for Ph3Sn(CH2)3OH against the A2780 ovarian carcinoma cell line.Betulinic acid regulates generation of neuroinflammatory mediators responsible for tissue destruction in multiple sclerosis in vitro.Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph₂PCH₂S(O)xPh (x = 0-2) ligands.Cationic arene ruthenium(II) complexes with chelating P-functionalized alkyl phenyl sulfide and sulfoxide ligands as potent anticancer agents.Melanoma tumor inhibition by tetrachlorido(O,O'-dibutyl-ethylenediamine-N,N'-di-3-propionate)platinum(IV) complex: in vitro and in vivo investigations.Platinum(II/IV) complexes containing ethylenediamine-N,N'-di-2/3-propionate ester ligands induced caspase-dependent apoptosis in cisplatin-resistant colon cancer cells.Liposomes as vehicles for water insoluble platinum-based potential drug: 2-(4-(tetrahydro-2H-pyran-2-yloxy)-undecyl)-propane-1,3-diamminedichloroplatinum(II).Novel methylene modified cyclohexyl ethylenediamine-N,N'-diacetate ligands and their platinum(IV) complexes. Influence on biological activity.Preliminary study of the anticancer applications of mesoporous materials functionalized with the natural product betulinic acid.Study of the anticancer properties of tin(IV) carboxylate complexes on a panel of human tumor cell lines.Study of the cytotoxicity and particle action in human cancer cells of titanocene-functionalized materials with potential application against tumors.Synthesis and anticancer activity of novel betulinic acid and betulin derivatives.Small structural changes of pentacyclic lupane type triterpenoid derivatives lead to significant differences in their anticancer properties.Carbamate derivatives of betulinic acid and betulin with selective cytotoxic activity.Synthesis and in vitro anticancer activity of octahedral platinum(IV) complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.In vitro anticancer studies of alpha- and beta-D-glucopyranose betulin anomers.Palladium(II) complexes with R2edda-derived ligands. Part II. Synthesis, characterization and in vitro antitumoral studies of R2eddip esters and palladium(II) complexes.Novel trans-dichloridoplatinum(II) complexes with 3- and 4-acetylpyridine: Synthesis, characterization, DFT calculations and cytotoxicity.Cytotoxic studies of substituted titanocene and ansa-titanocene anticancer drugs.Platinum(II) complexes with l-methionylglycine and l-methionyl-l-leucine ligands: synthesis, characterization and in vitro antitumoral activity.Aloe emodin decreases the ERK-dependent anticancer activity of cisplatin.N,N'-Bis[2-(methoxycarbonyl)ethyl]ethane-1,2-diammonium dichloride.(S,S)-N,N'-Bis(1-carb-oxy-2-methyl-prop-yl)ethyl-enediammonium dihalide cyclo-penta-nol tetra-solvate (halide = bromide/chloride ≃ 1:12).2,2'-{1,1'-[2,2'-Oxalylbis(hydrazin-2-yl-1-yl-idene)]diethyl-idyne}dipyridinium bis-(perchlorate) dihydrate.Hexaaqua-magnesium(II) bis-(d-camphor-10-sulfonate).Improvement of cytotoxicity of titanocene-functionalized mesoporous materials by the increase of the titanium content.Gold(III) complexes with esters of cyclohexyl-functionalized ethylenediamine-N,N'-diacetate.Tetraaquabis(D-camphor-10-sulfonato)calcium(II).Novel platinum(IV) complexes induce rapid tumor cell death in vitro.Delivery of [Ru(η6-p-cymene)Cl2{Ph2P(CH2)3SPh-κP}] using unfunctionalized and mercapto functionalized SBA-15 mesoporous silica: Preparation, characterization and in vitro study.Silicon-based nanotheranostics.In vitro effects of binuclear (η (6)-p-cymene)ruthenium(II) complex containing bridging bis(nicotinate)-polyethylene glycol ester ligand on differentiation pathways of murine Th lymphocytes activated by T cell mitogen.Drug Delivery System for Emodin Based on Mesoporous Silica SBA-15.
P50
Q30313327-A5B41DB7-EA98-4B9E-B709-7AF9F494479DQ30316886-3F723D6C-4B77-431E-8629-B947D3CBC7D6Q31048459-735B00CF-07D6-43A6-A1DE-7C115FE17D75Q34818345-D8D62348-D333-4A0A-9514-A073A5B99D5AQ36345731-1E7A6019-0E7D-436B-8951-10927E0DE8CFQ37932579-81A3CD80-7368-43BC-913F-1E56E959EFC5Q38590667-E79EE6F0-1348-4287-928D-B12E50363557Q38730893-973C47EB-4939-4D7F-AE31-F3283D942B67Q39014507-0557208D-76BC-409A-93A8-75C0C289FFBEQ39094988-C36B2B88-DCEC-4756-B37C-5DC138D8E6E1Q39206559-6F0023DA-2267-459D-B2AB-A79E325D9865Q39270889-F6FE9EF7-ED92-41BC-B321-57A687204C0DQ39310363-D5410C86-6DB6-4842-A321-01B70AC48021Q39322330-F4E0DDA2-5224-4C11-A15C-0C04ADEB03AFQ39389516-DBDD6B07-6B46-4EDF-92EA-460983401007Q39406009-5ACE7C5B-7A67-498A-8222-1E53234B76D7Q39428358-42AD0DC2-0D54-45DA-8763-DE320D6C177FQ39438051-3ADE9AF3-AA18-4041-B7FA-69087D1C089FQ39665242-D8E3DE64-58C4-4A69-A17B-FA7ADAFA288DQ39703569-256CF658-8005-4854-ACA2-C7FBA2E58508Q39706434-6765F8C9-1BF7-4A8D-B3C8-67EA8DD9D312Q39712439-7194571C-ECAF-4F65-9DAE-A51B8280569CQ39733738-F500A9BA-5EFB-4DDE-AD12-D0C00F49BBCEQ39875281-94610AD0-4348-4F83-B1CE-5513CD6ADA8DQ39906898-062CA215-CEC7-4394-BA0F-B864400CC52FQ40000657-A37040AC-728D-4272-B60A-4CBF41E1ACA1Q40183193-E7589490-1DB4-4859-A9A5-38703ED04D56Q40419631-1070EB8A-E4F2-43D3-8D06-96950089C381Q41817411-54D46CD9-0520-4F99-9C33-6695F0A7306FQ41852378-4354C234-E368-47C8-A914-340AB4A11956Q41861509-FE2C8851-D05B-4DF6-BC83-14F9B647205EQ42402559-B6246210-0142-4755-955F-96A69DEF61ECQ43152227-82C073F4-FAD5-4D4F-A0F0-408C1F3BAB43Q45277618-B592191C-2AF6-4449-A33D-267C91344A1FQ46061099-B20DB31D-A93F-4874-B3C9-125F840910FBQ48936228-93458D4B-D4B9-42E2-B878-69DCDBCE6FD2Q49390733-4F1925F8-CCA5-4C00-8F62-8258DCD4B80BQ50275652-7D19E36D-3A65-437B-A7C1-BCE5F64E164CQ54168463-DD9CB61B-5B79-47BF-9597-4FA0E946CDBAQ55087407-A0AC5C29-9077-4D84-965B-CC04539E89FF
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Goran N Kaluđerović
@ast
Goran N Kaluđerović
@en
Goran N Kaluđerović
@es
Goran N Kaluđerović
@nl
Goran N Kaluđerović
@sl
type
label
Goran N Kaluđerović
@ast
Goran N Kaluđerović
@en
Goran N Kaluđerović
@es
Goran N Kaluđerović
@nl
Goran N Kaluđerović
@sl
prefLabel
Goran N Kaluđerović
@ast
Goran N Kaluđerović
@en
Goran N Kaluđerović
@es
Goran N Kaluđerović
@nl
Goran N Kaluđerović
@sl
P1053
E-6310-2013
P106
P21
P31
P3829
P496
0000-0001-5168-1000